Abstract
The present study investigated the effects of nesfatin-1 on gastric distension (GD)-responsive neurons via an interaction with corticotropin-releasing factor (CRF) receptor signaling in the ventromedial hypothalamic nucleus (VMH), and the potential regulation of these effects by hippocampal projections to VMH. Extracellular single-unit discharges were recorded in VHM following administration of nesfatin-1. The projection of nerve fibers and expression of nesfatin-1 were assessed by retrograde tracing and fluoro-immunohistochemical staining, respectively. Results showed that there were GD-responsive neurons in VMH; Nesfatin-1 administration and electrical stimulation of hippocampal CA1 sub-region altered the firing rate of these neurons. These changes could be partially blocked by pretreatment with the non-selective CRF antagonist astressin-B or an antibody to NUCB2/nesfatin-1. Electrolytic lesion of CA1 hippocampus reduced the effects of nesfatin-1 on VMH GD-responsive neuronal activity. These studies suggest that nesfatin-1 plays an important role in GD-responsive neuronal activity through interactions with CRF signaling pathways in VMH. The hippocampus may participate in the modulation of nesfatin-1-mediated effects in VMH.
Introduction
Satiety is a complex physiological state governed by the integration of mechanical signals from the gastrointestinal tract and chemical signals within the brain. Nesfatin-1, an anorexigenic peptide derived from nucleobindin-2 (NUCB2), is a critical player in appetite regulation. While its role in the hypothalamus is well-documented, the specific neural circuitry through which it modulates the brain's response to physical fullness—specifically gastric distension (GD)—remains a subject of active investigation. This study focuses on the Ventromedial Hypothalamic Nucleus (VMH), a primary "satiety center," and explores how Nesfatin-1 influences GD-responsive neurons and the role of hippocampal projections in this process.
Methods
The researchers utilized adult male Wistar rats to map this neural circuit. Electrophysiology was employed to record extracellular single-unit discharges from VMH neurons while simulating fullness via a gastric balloon. Micro-pressure injections delivered Nesfatin-1 and antagonists like the CRF blocker astressin-B directly into the VMH. To map physical connections, retrograde tracing (Fluoro-Gold) and immunohistochemical staining were used. Finally, the role of the hippocampus was assessed through electrical stimulation of the CA1 sub-region and electrolytic lesions to observe changes in VMH neuronal activity.
Results
Prevalence and Dose-Response
Of the recorded VMH neurons, 68.1% were found to be responsive to gastric distension. Nesfatin-1 administration significantly altered the firing rates of these neurons in a dose-dependent manner.
As shown in the figure above, increasing concentrations of Nesfatin-1 (from 0.5 nM to 150 nM) led to a progressive increase in the discharge rate (spikes/s), with a half-maximal response observed at approximately 10 nM.
Dual-Action Modulation and CRF Signaling
The study revealed that Nesfatin-1 acts as a fine-tuner of satiety signals. It decreased the firing rate of excitatory GD neurons (GD-E) while increasing the firing rate of inhibitory GD neurons (GD-I). Crucially, these effects were mediated by Corticotropin-Releasing Factor (CRF) signaling.
Pretreatment with the CRF antagonist astressin-B significantly blunted the effects of Nesfatin-1 on both GD-E and GD-I neurons (Figure 2C), suggesting that Nesfatin-1 utilizes stress-related signaling pathways to regulate appetite.
Hippocampal Integration
Neuroanatomical tracing confirmed direct projections from Nesfatin-1-expressing neurons in the hippocampal CA1 region to the VMH. Electrical stimulation of the CA1 mimicked Nesfatin-1's effects, whereas electrolytic lesions of the CA1 significantly reduced the VMH's response to Nesfatin-1. This identifies the hippocampus as a functional modulator of metabolic signaling.
Discussion
These findings establish a clear neural pathway where Nesfatin-1 modulates the excitability of GD-responsive neurons in the VMH through an interaction with CRF signaling. The involvement of the hippocampus suggests that "fullness" is not merely a homeostatic signal but is integrated into broader behavioral and cognitive states.
While this study provides robust electrophysiological evidence, it is limited by a lack of direct behavioral data on food intake following these specific circuit manipulations. Future research should investigate how these neuronal changes translate to actual eating behavior and explore the potential for targeting this CA1-VMH-CRF axis in the treatment of metabolic disorders like obesity.
Summary updated